HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo-controlled study in postmenopausal women

✍ Scribed by T. E. VOGELVANG; J. R. LEURS; V. MIJATOVIC; J. WILLEMSE; M. J. VAN DER MOOREN

• Book ID: 109148961
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 152 KB
• Volume: 3
• Category: Article
• ISSN: 1538-7933
• DOI: 10.1111/j.1538-7836.2005.01306.x